HCA Holdings (HCA) Holders to Sell 50M Shares
Tweet Send to a FriendGet Alerts HCA Hot Sheet
Price: $38.83 -1.1%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 5.2%
Revenue Growth %: +0.4%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 5.2%
Revenue Growth %: +0.4%
Trade HCA Now!
HCA Holdings (NYSE: HCA) announced that certain of its stockholders, consisting principally of affiliates of, or funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co., intend to offer for sale in an underwritten at-the-market secondary offering approximately 50 million shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission.
The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by management or the Company.
Barclays Capital Inc. and Citigroup Global Markets Inc. will act as underwriters for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by management or the Company.
Barclays Capital Inc. and Citigroup Global Markets Inc. will act as underwriters for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- HCA Makes Computerworld’s List of 100 Best Places to Work in Information Technology for Fifth Consecutive Year
- Pacific Coast Oil Trust (ROYT) Fils 20.08M Common Shelf for Shareholders
- SolarCity (SCTY) Files 2.8M Common Secondary; Elon Musk Plans Purchase
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Citi, Bain Capital, Kohlberg Kravis Roberts, BarclaysLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

